Our Firm continues to hear from individuals who may have experienced the serious complications associated with these devices.
New York, NY (PRWEB) February 24, 2014
A federal judge presiding over the multidistrict Stryker hip recall (http://www.strykerhiprecallclaims.com/) litigation in Minnesota has sought input from state court jurists on how to coordinate similar claims over the metal hip replacement, Bernstein Liebhard LLP reports.
According to a letter issued on February 18th in the U.S. District Court for the District of Minnesota, the federal judge overseeing lawsuits involving the Stryker Rejuvenate and ABG II modular-neck hip stems is requesting input on how the coordination of claims among state and federal litigations could “effectuate a meaningful and prompt resolution of those cases.” At the time the document was sent to judges in Michigan, Oregon and Illinois, Judge Frank noted that 100 cases over the metal hip replacements had been filed in these courts, and approximately 575 Stryker hip recall claims were pending in the federal litigation.
The federal judge also predicted that 1,000 additional lawsuits alleging pain, swelling and symptoms associated with metallosis would be filed over the Stryker Rejuvenate and ABG II devices over the coming months. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)
“As our Firm continues to hear from individuals who may have experienced the serious complications associated with these devices, we continue to monitor all related proceedings,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to individuals who may have been injured by the Stryker Rejuvenate and/or ABG II modular-neck hip stems.
Stryker Hip Recall
Court documents indicate that the number of federally-filed Stryker hip recall lawsuits is continuing to increase in the District of Minnesota. As of February 19th, an update from the U.S. Judicial Panel on Multidistrict Litigation (JPML) showed 576 claims pending in the Southern District of Minnesota on behalf of individuals who allege injuries associated with a voluntary recall issued almost two years ago by Stryker Orthopaedics. This recall was announced by the U.S. Food and Drug Administration (FDA) on July 6, 2012 after company data revealed the potential for components to fret and corrode at the modular-neck junction, which may result in premature failure of the device. According to recent records, the most recent Case Management Conference in the federal multidistrict Stryker lawsuit litigation took place on February 20, 2014.
Stryker lawsuits are also progressing in New Jersey’s Bergen County Superior Court, where claimants similarly allege that the general public was inadequately warned about the risks associated with the Rejuvenate and ABG II modular-neck hip stems prior to their July 2012 recall. Given the potential for these devices to cause pain, swelling and other complications that often require removal via revision surgery, plaintiffs allege that they were defectively designed by Stryker Orthopaedics. A Case List updated on February 19th indicates that 779 cases have now been filed in the New Jersey Superior Court litigation. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
In the two years since the Stryker Rejuvenate and ABG II modular-neck hip stems were recalled, their manufacturer has advised on its website that all recipients undergo routine blood testing and cross-sectional imaging to monitor for elevated metal ion levels in the blood stream.*
Individuals who were allegedly injured by the Stryker Rejuvenate or ABG II modular-neck hip stems may be eligible to file a lawsuit against the manufacturer of these metal hips. Learn more about Stryker hip lawsuits by visiting the Bernstein Liebhard LLP’s website, or by calling the Firm directly for a free and confidential review of your case at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP